LifeScience

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Cell and Gene Therapy Specialty Building on years of cell and gene therapy expertise, Matica Bio’s new facility is now expanding its capacity as a C...

 May 04, 2022 | News

Biocytogen Enters into Antibody Agreement with Merck

Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...

 May 02, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

 April 27, 2022 | News

Thermo Fisher opens bioprocessing manufacturing facility in Ogden, UT

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility cre...

 April 21, 2022 | News

MGI announces partnership with Nalagenetics to advance personalized medicine

MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to co-develop lo...

 April 19, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

 April 14, 2022 | News

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

 April 13, 2022 | News

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it clos...

 April 12, 2022 | News

Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US

PRG-1801 is a single domain antibody anti-BCMA CAR-T cell therapy in development for the treatment of relapsed/refractory multiple myeloma that has demonst...

 April 07, 2022 | News

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

 Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...

 April 05, 2022 | News

BioVaxys Expands Cancer Vaccine Platform

BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer vaccine platf...

 March 31, 2022 | News

Fujifilm to Acquire Shenandoah Biotechnology

Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies FUJIFI...

 March 24, 2022 | News

Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...

 March 23, 2022 | News

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

 March 23, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close